{"id":4481,"date":"2018-07-04T09:46:15","date_gmt":"2018-07-04T07:46:15","guid":{"rendered":"https:\/\/www.hal-allergy.com\/?page_id=4481"},"modified":"2018-09-04T17:26:22","modified_gmt":"2018-09-04T15:26:22","slug":"noticias","status":"publish","type":"page","link":"https:\/\/www.hal-allergy.com\/es\/noticias\/","title":{"rendered":"Noticias"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><section class=\"l-section wpb_row height_huge with_img\"><div class=\"l-section-img\" style=\"background-image: url(https:\/\/www.hal-allergy.com\/wp-content\/uploads\/2018\/07\/night_building_large_with-HALIX-e1530608884651.jpg);\" data-img-width=\"5564\" data-img-height=\"1488\"><\/div><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row type_default valign_top\"><div class=\"vc_col-sm-12 vc_hidden-lg vc_hidden-md vc_hidden-sm wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-separator type_invisible size_large\"><\/div><div class=\"w-separator type_invisible size_large\"><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row type_default valign_top\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column \">\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<h3><span style=\"color: #01478e;\">Noticias<\/span><\/h3>\n<h5><span id=\"result_box\" class=\"\" lang=\"es\" tabindex=\"-1\"><span style=\"color: #01478e;\">Mant\u00e9ngase actualizado sobre los \u00faltimos desarrollos en HAL Allergy<\/span><\/span><\/h5>\n<p>Si es un paciente y ha sufrido un efecto secundario despu\u00e9s de utilizar uno de los productos de HAL Allergy, p\u00f3ngase en contacto con el m\u00e9dico que se lo recet\u00f3 o con HAL Allergy.\u00a0Puede encontrar una descripci\u00f3n general de las filiales de HAL Allergy aqu\u00ed.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row type_default valign_top\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column \">\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<style>.wp-show-posts-columns#wpsp-8347 {margin-left: -2em; }.wp-show-posts-columns#wpsp-8347 .wp-show-posts-inner {margin: 0 0 2em 2em; }<\/style><section id=\"wpsp-8347\" class=\" wp-show-posts\" style=\"\"><article class=\" wp-show-posts-single wpsp-clearfix post-14959 post type-post status-publish format-standard hentry category-sin-categorizar\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/es\/2025\/03\/19\/hal-allergy-announces-dr-philip-boehme-as-new-ceo-as-of-april-1st\/\" rel=\"bookmark\">HAL Allergy announces Dr. Philip Boehme as new CEO as of April 1st<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Leiden (The Netherlands, 19.03.2025) &#8211; As of April 1st, Dr. Philip Boehme, a medical doctor, chemical engineer and scientist, will join HAL Allergy as CEO, bringing in his deep R&amp;D&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"HAL Allergy announces Dr. Philip Boehme as new CEO as of April 1st\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/es\/2025\/03\/19\/hal-allergy-announces-dr-philip-boehme-as-new-ceo-as-of-april-1st\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14813 post type-post status-publish format-standard hentry category-sin-categorizar\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/es\/2024\/12\/19\/dr-werner-lanthaler-appointed-chairman-of-the-supervisory-board-of-hal-allergy\/\" rel=\"bookmark\">Dr Werner Lanthaler appointed Chairman of the Supervisory Board of HAL Allergy<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Leiden, The Netherlands, December 18th 2024 \u2013 HAL Allergy is pleased to announce the appointment of Dr Werner Lanthaler as Chairman of its Supervisory Board. Dr Werner Lanthaler brings over&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Dr Werner Lanthaler appointed Chairman of the Supervisory Board of HAL Allergy\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/es\/2024\/12\/19\/dr-werner-lanthaler-appointed-chairman-of-the-supervisory-board-of-hal-allergy\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14404 post type-post status-publish format-standard hentry category-sin-categorizar\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/es\/2024\/03\/22\/las-primeras-entregas-se-han-reanudado-con-exito\/\" rel=\"bookmark\">Las primeras entregas se han reanudado con \u00e9xito<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Tras el ataque de ransomware del pasado 19 de febrero, se han restaurado varios de los sistemas inform\u00e1ticos de HAL Allergy. Los sistemas recuperados se activaron gradualmente en las \u00faltimas&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Las primeras entregas se han reanudado con \u00e9xito\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/es\/2024\/03\/22\/las-primeras-entregas-se-han-reanudado-con-exito\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14280 post type-post status-publish format-standard hentry category-sin-categorizar\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/es\/2024\/02\/22\/declaracion-de-notificacion\/\" rel=\"bookmark\">DECLARACI\u00d3N DE NOTIFICACI\u00d3N<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Incidente de ciberseguridad en el fabricante y proveedor de inmunoterapia con al\u00e9rgenos HAL Allergy B.V. En la ma\u00f1ana del lunes 19 de febrero de 2024, HAL Allergy sufri\u00f3 un ataque&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"DECLARACI\u00d3N DE NOTIFICACI\u00d3N\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/es\/2024\/02\/22\/declaracion-de-notificacion\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-13858 post type-post status-publish format-standard hentry category-sin-categorizar\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/es\/2021\/07\/08\/alex-huybens-appointed-as-chief-executive-officer-ceo-of-hal-allergy-holding-b-v-and-halix-b-v\/\" rel=\"bookmark\">Alex Huybens appointed as Chief Executive Officer (CEO) of HAL Allergy Holding B.V. and HALIX B.V.<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-content\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p><em>Leiden (The Netherlands, 01.07.<\/em><em>2021)<\/em> \u2013 As of 1 July 2021, the Supervisory Board of the HAL Allergy Group has appointed Alex Huybens as Chief Executive Officer (CEO) and Member of the Board of HAL Allergy Holding B.V., as well as CEO of HALIX B.V.<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-content -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Alex Huybens appointed as Chief Executive Officer (CEO) of HAL Allergy Holding B.V. and HALIX B.V.\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/es\/2021\/07\/08\/alex-huybens-appointed-as-chief-executive-officer-ceo-of-hal-allergy-holding-b-v-and-halix-b-v\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-8914 post type-post status-publish format-standard hentry category-sin-categorizar\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/es\/2018\/08\/14\/hal-allergy-first-company-to-achieve-marketing-authorisations-in-line-with-therapieallergene-verordnung-tav-in-germany\/\" rel=\"bookmark\">HAL Allergy first company to achieve marketing authorisations in line with Therapieallergene-Verordnung (TAV) in Germany<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-content\" itemprop=\"text\">\n\t\t\t\t\t\t\t<h5>Registration of SUBLIVAC\u00ae Birch and SUBLIVAC\u00ae Trees 40.000\u00a0AUN\/ml in Germany accomplished<\/h5>\n<p>Leiden, the Netherlands (14 August 2018) \u2013 HAL\u00a0Allergy B.V. today announced the registration of SUBLIVAC\u00ae\u00a0Birch 40.000\u00a0AUN\/ml and SUBLIVAC\u00ae\u00a0Trees 40.000\u00a0AUN\/ml in Germany. These are the first marketing authorisations granted by the Paul Ehrlich Institute following the German Therapieallergene\u2011Verordnung (TAV).<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-content -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"HAL Allergy first company to achieve marketing authorisations in line with Therapieallergene-Verordnung (TAV) in Germany\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/es\/2018\/08\/14\/hal-allergy-first-company-to-achieve-marketing-authorisations-in-line-with-therapieallergene-verordnung-tav-in-germany\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><\/section><!-- .wp-show-posts -->\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n<\/div>","protected":false},"excerpt":{"rendered":"Registration of SUBLIVAC\u00ae Birch and SUBLIVAC\u00ae Trees 40.000\u00a0AUN\/ml in Germany accomplished Leiden, the Netherlands (14 August 2018) \u2013 HAL\u00a0Allergy B.V. today announced the registration of SUBLIVAC\u00ae\u00a0Birch 40.000\u00a0AUN\/ml and SUBLIVAC\u00ae\u00a0Trees 40.000\u00a0AUN\/ml in Germany. These are the first marketing authorisations granted by the Paul Ehrlich Institute following the German Therapieallergene\u2011Verordnung (TAV). The TAV was initiated by the...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"footnotes":""},"class_list":["post-4481","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/pages\/4481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/comments?post=4481"}],"version-history":[{"count":6,"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/pages\/4481\/revisions"}],"predecessor-version":[{"id":9171,"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/pages\/4481\/revisions\/9171"}],"wp:attachment":[{"href":"https:\/\/www.hal-allergy.com\/es\/wp-json\/wp\/v2\/media?parent=4481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}